Global Metabolomics Market

Metabolomics Market: Insights

The study of metabolites is known as metabolomics. Metabolites are the molecular by-products of the cellular process taking place in our body. By studying metabolites, researchers can identify and study the physiological state of the body. Metabolites help to study the metabolic processes taking place within the body, thereby acting as precursors to study the characteristics, metabolic activity, and thereby the health and functioning of the organism. Metabolites are in essence the intermediary by-products created during the enzyme-catalyzed metabolic reactions occurring within the body. As metabolites help study the characteristics or traits of the organism by studying its metabolome. Recent advancements in the analysis techniques of metabolites have seen the metabolomics market grow as they are being widely recognized as a tool to create cellular profiles. The market is driven by technological advancements made in the field of metabolic disease testing, the growing usage of metabolomics in preparing personalized and generic medicines, and the growing incidences of chronic diseases like cardiovascular diseases and cancers. The high initial costs of instruments and the need for highly qualified personnel to operate such machines greatly impact the growth of the metabolomics market.

Metabolomics Market: By Product & Services

The metabolomics market can be segmented as metabolomics instruments and services. The instruments segment includes separation tools like gas chromatography and detection tools like mass spectrometry, whereas the bioinformatics tools and services which include bioinformatics services & bioinformatics tools and databases. The instruments segment is analyzed to be the dominant segment with the highest market share and is also expected to grow at the fastest rate from 2021-2026. The separation tools segment is the dominant market sub-segment. The metabolomics instruments are seen as a one-time investment after which they can be used multiple times while services would require research and diagnosis centers to send samples to an external agency. Transporting samples is not ideal as it increases the chances of contamination and increases the chances of getting false results. Technological advancements in the instruments segment combined with the growing adoption of metabolomics research in the pharmaceuticals industry are the major drivers of this segment.        

Metabolomics Market: By Application

Based on the application of metabolomics, the market can be segmented into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications. The biomarker discovery segment is the dominant segment as biomarkers are being widely used to determine the physiological state of the body. Biomarkers are used extensively to study diseases and their severity within the body. Pharmaceutical industries are beginning to implement using the biomarker-based metabolomic analysis to study the progression and presence of disease in the body. The increased usage by pharmaceutical companies and other industries to study diseases and their impact on the body are the major drivers of this segment.

Metabolomics Market: By Indication

Based on the indications gleaned from the information attained through metabolomics, the metabolomics market can be segmented as cancer, cardiovascular diseases, neurological diseases, metabolic disorders, inborn errors of metabolism, and other indicators. The cancer segment is the dominant market segment while also being the fastest-growing segment. The growing incidences of cancer in recent years have seen more and more investments in cancer research which has contributed significantly to the growth of this segment. As metabolomic studies help doctors to study the progression of the disease within the body, for a disease like cancer whose treatment is contingent on the severity of the disease it is of no surprise that this segment holds the dominant market share.

Metabolomics Market: By End-User

The metabolomics market can be segmented into academic and research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end-users as per the end-user analysis. The academic and research institutes held the largest share of the market as the investment in metabolomics research has increased several-fold in recent years. The pharmaceutical & biotechnology companies segment is the fastest-growing segment as metabolomics is being widely accepted in the synthesis of new medicines.  Academic & research institutes have been studying metabolomics for years to come up with faster and efficient methods to study the characteristics of the human body when it’s under attack from diseases. With rapid progress in technology, they’ve increased the number of metabolomic studies being conducted which has resulted in a dominant market share. With research institutes coming up with novel metabolomics-based techniques to study diseases and their progress within the human body, pharmaceutical companies are increasing the usage of metabolomic studies to create new medicines.

Metabolomics Market: By Company Types

Based on company types, the metabolomics industry is segmented into tier 1, tier 2, and tier 3 pharmaceutical companies. The tier 1 pharmaceutical companies segment is the dominant segment while the tier 2 pharmaceutical companies segment is the fastest-growing segment. Tier 1 pharmaceutical companies have larger revenue streams that allow them to absorb the heavy equipment cost of metabolomic instruments.

Metabolomics Market: By Region

The North American region held the largest share of the market. The high healthcare spending by governments and increased investments in medical research & development. The North American region’s population is an aging population and the general cost of healthcare in the region is quite high. With such high costs, the public expects the best and advanced treatments possible in the region. The Asia Pacific (APAC) region will be the fastest-growing region. The growing number of pharmaceutical companies in the region and increased research funding is expected to contribute to the growth of the market in this region. The pharmaceuticals manufacturing industry has been thriving in the APAC region, and to increase and maintain their growth it is necessary for them to keep up to date with the advancements occurring in the field. This has seen pharmaceutical industries implement metabolomic solutions and increase funding for metabolomic study in the region.

Metabolomics Market: Share & Competitor Analysis

Waters Corporation, Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific, Danaher Corporation, Bruker Corporation, PerkinElmer, Merck KGaA, GE Healthcare, Hitachi High-Technologies Corporation, Human Metabolome Technologies Inc., LECO Corporation, Metabolon, Inc., Bio-Rad Laboratories, Scion Instruments, DANI Instruments S.p.A., GL Sciences, SRI Instruments, Kore Technology Ltd., and JASCO Inc., among others, are the major vendors competing in the metabolomics market.

Please note: This is not an exhaustive list of companies profiled in the report.